Iliopsoas Nerve Block and Femoral Nerve Block in Hip Fracture Surgeries
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Iliopsoas nerve block, Femoral nerve block.
- Who it may be relevant to
- Registry conditions: Iliopsoas Nerve Block, Femoral Nerve Block, Hip Fracture Surgeries. Basic parameters: 18 years — 65 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Comparison Between Iliopsoas Nerve Block and Femoral Nerve Block in Hip Fracture Surgeries
Overview
This study aims to compare iliopsoas nerve Block (IPB) to femoral nerve block (FNB) regarding pain control, patient satisfaction, and early ambulation in patients undergoing hip fracture surgeries
Detailed description
Hip fractures are among the most frequent fractures seen in the emergency department and orthopedic trauma teams. The terms hip fracture and neck of femur fracture are used synonymously. Both terms describe a proximal femur fracture between the femoral head and 5 cm distal to the lesser trochanter.
Iliopsoas nerve Block (IPB) is a promising motor-sparing analgesic technique that selectively targets the sensory branches of the hip joint originating from the femoral nerve and accessory obturator nerve, sparing the motor supply of quadriceps muscles.
A femoral nerve block (FNB) is a simple nerve block that can be performed easily without or under ultrasound guidance. Under ultrasound guidance, the femoral artery and femoral nerve were identified clearly, and a needle was inserted using an in-plane approach from the lateral to the medial direction. Once the needle tip's position was confirmed, 10 ml of 0.5% bupivacaine was injected adjacent to the femoral nerve.
Interventions
- Drug Iliopsoas nerve block
Patients will receive an Iliopsoas nerve block using 10 ml of bupivacaine 0.5%. - Drug Femoral nerve block
Patients will receive femoral nerve block using 10 ml of bupivacaine 0.5%.
Primary outcome measures
- Degree of pain [Time frame: 24 hours postoperatively]
Secondary outcome measures (5)
- Total opioids consumption [Time frame: 24 hours postoperatively]
- Assessment of quadriceps strength [Time frame: 24 hours postoperatively]
- Time of ambulation [Time frame: 24 hours postoperatively]
- Patients' satisfaction [Time frame: 24 hours postoperatively]
- Incidence of complications [Time frame: 24 hours postoperatively]
Eligibility criteria
Inclusion criteria
- Age from 18 to 65 years.
- Both sexes.
- American Society of Anesthesiologists (ASA) physical status I and II.
- Patients who are scheduled for elective surgical correction of hip fracture either through open fracture internal fixation (ORIF), partial hip arthroplasty or total hip arthroplasty.
Exclusion criteria
- Refusal to participate.
- Coagulopathy.
- Patients with a history of drug allergies to study drugs.
- Inability to cooperate.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Egypt · 1 center
- Ain Shams University — Cairo
Identifiers
NCT: NCT06852378 · FMASU MD38/2025